跳至主要内容
临床试验/PACTR202108668389918
PACTR202108668389918已完成未知

impact of tranexamic acid on the prevention of hemorrhage during and after cesarean section in parturients at risk.

niversity Hospital Lamine Debaghine Bab El Oued0 个研究点目标入组 796 人开始时间: 2021年8月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
796

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • - Scheduled or semi-emergency cesarean section.
  • - Live fetus.
  • - Gestational age greater than or equal to 35 SA.
  • - Parturients classified as ASA I or ??,consenting, with 2 or more risk factors for postpartum hemorrhage:
  • * polyhydramnios.
  • * age greater than 35 years.
  • * Fetal macrosomia.
  • * coagulation anomaly.
  • * thrombopenia.
  • * anticoagulant treatment.
  • * antecedents of postpartum hemorrhage.
  • * placenta pravea not recovering.
  • * Pre-eclampsia.
  • * Multiple pregnancy.
  • * Multiple pregnancy.
  • * Chorioamniotitis.

排除标准

  • - Allergy to tranexamic acid.
  • - Severe renal impairment.
  • - History of thrombosis.
  • - Epilepsy.
  • - Death in utero
  • - Severe medical or surgical complication involving the heart, liver, kidneys, or brain.
  • - Placental insertion anomalies: placenta accreta and covering pravea.
  • - Caesarean sections performed for active bleeding during uterine rupture, retro placental hematoma, or placenta previa.

研究者

发起方
niversity Hospital Lamine Debaghine Bab El Oued

相似试验